Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stent implantation following acute myocardial infarction is safe and feasible, studies show.

This article was originally published in The Gray Sheet

Executive Summary

STENT IMPLANTATION WITHIN FIRST WEEK OF ACUTE MYOCARDIAL INFARCTION resulted in a 94% rate of angiographic success among 33 patients, Michael Le May, MD, University of Ottawa Heart Institute, Canada, reported March 25 at the American College of Cardiology scientific sessions in Orlando, Florida. Le May said that the experience of the 33 patients -- who received stent implants within seven days of first experiencing acute myocardial infarction -- also showed that "the thrombogenic risk of stenting patients within the first week of AMI is small." Therefore, he concluded, "stenting is a useful adjunct to balloon angioplasty."

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005763

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel